# AGR2

## Overview
AGR2 (anterior gradient 2) is a gene that encodes a protein belonging to the protein disulfide isomerase (PDI) family, which is involved in the formation and rearrangement of disulfide bonds in proteins. The AGR2 protein, characterized by a thioredoxin fold structure, plays a crucial role in the endoplasmic reticulum (ER) by facilitating the proper folding and processing of secretory proteins, particularly mucins, which are essential for maintaining epithelial barrier integrity (Mohtar2018The; Maslon2010A). AGR2 is expressed in various tissues, including the gastrointestinal, respiratory, and reproductive systems, and is implicated in processes such as mucus production, epithelial cell homeostasis, and protection against inflammatory diseases (Kosykh2023Potential). Additionally, AGR2 is associated with cancer progression, where its overexpression is linked to enhanced tumor growth and metastasis, making it a potential target for therapeutic interventions (Alsereihi2019Leveraging; Chevet2012Emerging).

## Structure
The anterior gradient 2 (AGR2) protein is a member of the protein disulfide isomerase (PDI) family and is characterized by a thioredoxin fold structure. This protein primarily exists in a monomer-dimer equilibrium, with a dissociation constant (K_d) of 8.83 μM, and its dimerization is crucial for its function (Patel2013MetastasisPromoting). The dimeric form of AGR2 is stabilized by intermolecular salt bridges, particularly involving residues E60 and K64, which are essential for maintaining the dimer interface (Maurel2019Control; Patel2013MetastasisPromoting).

AGR2 contains a thioredoxin domain with a CXXS motif, which is a variant of the typical CXXC motif found in other PDI family members. This motif is involved in the isomerization of disulfide bonds, although AGR2 exhibits lower activity compared to other PDIs (Maslon2010A). The protein also features a hydrophobic patch surrounding the CPHS motif, which may be involved in binding target proteins (Patel2013MetastasisPromoting).

Structurally, AGR2 has an unstructured N-terminal region and a C-terminal ER-retention sequence (KTEL), which localizes it to the endoplasmic reticulum (Mohtar2018The). The protein's dimerization is not essential for its cell adhesion properties, as both monomeric and dimeric forms exhibit similar adhesion efficiencies (Patel2013MetastasisPromoting). AGR2 is also known to form mixed disulfides with substrates like Mucin 2 (MUC2), facilitating their maturation and folding (Maslon2010A).

## Function
AGR2 (anterior gradient 2) is a protein that plays a significant role in the production of intestinal mucus by facilitating the proper folding and processing of the MUC2 protein, a key component of mucus. It is localized within the endoplasmic reticulum (ER) of intestinal secretory epithelial cells, particularly in goblet and Paneth cells, where it forms mixed disulfide bonds with MUC2. This interaction is crucial for the proper synthesis and secretion of mucus, which is essential for maintaining intestinal health (Park2009The).

AGR2 is a member of the protein disulfide isomerase (PDI) family and is involved in the regulation of protein folding within the ER through its disulfide isomerase activity. This activity assists in the formation and isomerization of disulfide bonds in client proteins, similar to a molecular chaperone, and is crucial for maintaining the balance between differentiated and stem epithelial cells (Kosykh2023Potential).

In addition to its role in mucus production, AGR2 is implicated in the regulation of epithelial cell homeostasis and protection against inflammatory diseases. It is expressed in various tissues, including the gastrointestinal, respiratory, and reproductive systems, and is associated with maintaining the integrity of epithelial barriers (Kosykh2023Potential).

## Clinical Significance
Mutations and alterations in the AGR2 gene are associated with various diseases and conditions, particularly in the context of cancer. AGR2 is overexpressed in several cancer types, including breast, prostate, lung, colorectal, ovarian, gastric, pancreatic, and esophageal cancers. This overexpression is linked to enhanced cancer cell growth, survival, and metastasis, often correlating with poor prognosis and resistance to therapies such as tamoxifen in breast cancer (Moidu2020Secretion; Alsereihi2019Leveraging; Chevet2012Emerging). AGR2's role in cancer involves its interaction with key signaling pathways, including those regulating genomic integrity, apoptosis, and angiogenesis, and its ability to inhibit tumor suppressor p53 activity (Alsereihi2019Leveraging; Chevet2012Emerging).

In addition to its role in cancer, AGR2 mutations have been linked to a disorder resembling cystic fibrosis, characterized by recurrent respiratory infections and impaired mucin production. This condition is associated with biallelic variants in AGR2, leading to structural changes that affect protein function and interactions (BertoliAvella2021A). AGR2 is also implicated in inflammatory diseases like asthma and inflammatory bowel disease, where its dysregulation can affect mucin production and epithelial cell function (Chevet2012Emerging).

## Interactions
AGR2, a member of the protein disulfide isomerase family, is involved in various protein interactions, particularly within the endoplasmic reticulum (ER). It forms complexes with mucins such as MUC-5AC and MUC-5B, playing a crucial role in mucin quality control under oxidizing conditions (Worfolk2019Elucidation). AGR2 also interacts with ER chaperones including GRP78/BiP, calnexin, and members of the PDI family like PDIA3, PDIA6, and ERp44, which are involved in protein folding and disulfide bond formation (Worfolk2019Elucidation).

AGR2's interaction with the oncogenic receptor EpCAM involves a specific peptide motif, indicating its role in protein folding and maturation during ER assembly (Mohtar2018The). It also forms mixed disulfide bonds with proteins such as EGFR, influencing their cell surface delivery and contributing to cancer progression (Delom2020The).

In addition to these interactions, AGR2 associates with proteins like ALDH3A1, PTGR1, TAGLN2, annexin A2, BCAP31, YWHAZ, and VAPA, suggesting a broad network of redox-responsive interactions (Worfolk2019Elucidation). These interactions highlight AGR2's multifaceted role in cellular processes, particularly in the context of cancer and protein homeostasis.


## References


[1. (Alsereihi2019Leveraging) Reem Alsereihi, Hans-Juergen Schulten, Sherin Bakhashab, Kulvinder Saini, Ahmed M. Al-Hejin, and Deema Hussein. Leveraging the role of the metastatic associated protein anterior gradient homologue 2 in unfolded protein degradation: a novel therapeutic biomarker for cancer. Cancers, 11(7):890, June 2019. URL: http://dx.doi.org/10.3390/cancers11070890, doi:10.3390/cancers11070890. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers11070890)

[2. (Mohtar2018The) M. Aiman Mohtar, Lenka Hernychova, J. Robert O’Neill, Melanie L. Lawrence, Euan Murray, Borek Vojtesek, and Ted R. Hupp. The sequence-specific peptide-binding activity of the protein sulfide isomerase agr2 directs its stable binding to the oncogenic receptor epcam. Molecular &amp; Cellular Proteomics, 17(4):737–763, April 2018. URL: http://dx.doi.org/10.1074/mcp.RA118.000573, doi:10.1074/mcp.ra118.000573. This article has 22 citations.](https://doi.org/10.1074/mcp.RA118.000573)

[3. (Maurel2019Control) Marion Maurel, Joanna Obacz, Tony Avril, Yong‐Ping Ding, Olga Papadodima, Xavier Treton, Fanny Daniel, Eleftherios Pilalis, Johanna Hörberg, Wenyang Hou, Marie‐Claude Beauchamp, Julien Tourneur‐Marsille, Dominique Cazals‐Hatem, Lucia Sommerova, Afshin Samali, Jan Tavernier, Roman Hrstka, Aurélien Dupont, Delphine Fessart, Frédéric Delom, Martin E Fernandez‐Zapico, Gregor Jansen, Leif A Eriksson, David Y Thomas, Loydie Jerome‐Majewska, Ted Hupp, Aristotelis Chatziioannou, Eric Chevet, and Eric Ogier‐Denis. Control of anterior <scp>gr</scp> adient 2 ( <scp>agr</scp> 2) dimerization links endoplasmic reticulum proteostasis to inflammation. EMBO Molecular Medicine, April 2019. URL: http://dx.doi.org/10.15252/emmm.201810120, doi:10.15252/emmm.201810120. This article has 48 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.15252/emmm.201810120)

[4. (Delom2020The) Frederic Delom, M. Aiman Mohtar, Ted Hupp, and Delphine Fessart. The anterior gradient-2 interactome. American Journal of Physiology-Cell Physiology, 318(1):C40–C47, January 2020. URL: http://dx.doi.org/10.1152/ajpcell.00532.2018, doi:10.1152/ajpcell.00532.2018. This article has 30 citations.](https://doi.org/10.1152/ajpcell.00532.2018)

[5. (Chevet2012Emerging) E Chevet, D Fessart, F Delom, A Mulot, B Vojtesek, R Hrstka, E Murray, T Gray, and T Hupp. Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development. Oncogene, 32(20):2499–2509, September 2012. URL: http://dx.doi.org/10.1038/onc.2012.346, doi:10.1038/onc.2012.346. This article has 118 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2012.346)

[6. (Maslon2010A) Magdalena M. Maslon, Roman Hrstka, Borek Vojtesek, and Ted R. Hupp. A divergent substrate-binding loop within the pro-oncogenic protein anterior gradient-2 forms a docking site for reptin. Journal of Molecular Biology, 404(3):418–438, December 2010. URL: http://dx.doi.org/10.1016/j.jmb.2010.09.035, doi:10.1016/j.jmb.2010.09.035. This article has 45 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2010.09.035)

[7. (Kosykh2023Potential) Anastasiya V. Kosykh, Maria B. Tereshina, and Nadya G. Gurskaya. Potential role of agr2 for mammalian skin wound healing. International Journal of Molecular Sciences, 24(9):7895, April 2023. URL: http://dx.doi.org/10.3390/ijms24097895, doi:10.3390/ijms24097895. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24097895)

[8. (Patel2013MetastasisPromoting) Pryank Patel, Christopher Clarke, Dong Liu Barraclough, Thomas Adam Jowitt, Philip Spencer Rudland, Roger Barraclough, and Lu-Yun Lian. Metastasis-promoting anterior gradient 2 protein has a dimeric thioredoxin fold structure and a role in cell adhesion. Journal of Molecular Biology, 425(5):929–943, March 2013. URL: http://dx.doi.org/10.1016/j.jmb.2012.12.009, doi:10.1016/j.jmb.2012.12.009. This article has 54 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2012.12.009)

[9. (Worfolk2019Elucidation) Jack C. Worfolk, Steven Bell, Lee D. Simpson, Naomi A. Carne, Sarah L. Francis, Vibecke Engelbertsen, Adrian P. Brown, Julie Walker, Yirupaiahgari K. Viswanath, and Adam M. Benham. Elucidation of the agr2 interactome in esophageal adenocarcinoma cells identifies a redox-sensitive chaperone hub for the quality control of muc-5ac. Antioxidants &amp; Redox Signaling, 31(15):1117–1132, November 2019. URL: http://dx.doi.org/10.1089/ars.2018.7647, doi:10.1089/ars.2018.7647. This article has 12 citations.](https://doi.org/10.1089/ars.2018.7647)

[10. (Park2009The) Sung-Woo Park, Guohua Zhen, Catherine Verhaeghe, Yasuhiro Nakagami, Louis T. Nguyenvu, Andrea J. Barczak, Nigel Killeen, and David J. Erle. The protein disulfide isomerase agr2 is essential for production of intestinal mucus. Proceedings of the National Academy of Sciences, 106(17):6950–6955, April 2009. URL: http://dx.doi.org/10.1073/pnas.0808722106, doi:10.1073/pnas.0808722106. This article has 325 citations.](https://doi.org/10.1073/pnas.0808722106)

[11. (BertoliAvella2021A) Aida Bertoli-Avella, Ronja Hotakainen, Maryam Al Shehhi, Alice Urzi, Catarina Pareira, Anett Marais, Khoula Al Shidhani, Sumaya Aloraimi, Galina Morales-Torres, Steffen Fisher, Laura Demuth, Laila Abdel Moteleb Selim, Nihal Al Menabawy, Maryam Busehail, Mohammed AlShaikh, Naser Gilani, Dler Nooruldeen Chalabi, Nasser S Alharbi, Majid Alfadhel, Mohammed Abdelrahman, Hanka Venselaar, Nadeem Anjum, Anjum Saeed, Malak Ali Alghamdi, Hamad Aljaedi, Hisham Arabi, Vasiliki Karageorgou, Suliman Khan, Zahra Hajjari, Mandy Radefeldt, Ruslan Al-Ali, Kornelia Tripolszki, Amer Jamhawi, Omid Paknia, Claudia Cozma, Huma Cheema, Najim Ameziane, Saleh Al-Muhsen, and Peter Bauer. A disorder clinically resembling cystic fibrosis caused by biallelic variants in the agr2 gene. Journal of Medical Genetics, 59(10):993–1001, December 2021. URL: http://dx.doi.org/10.1136/jmedgenet-2021-108150, doi:10.1136/jmedgenet-2021-108150. This article has 5 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/jmedgenet-2021-108150)

[12. (Moidu2020Secretion) Nurshahirah Ashikin Moidu, Nisa Syakila A Rahman, Saiful Effendi Syafruddin, Teck Yew Low, and M. Aiman Mohtar. Secretion of pro-oncogenic agr2 protein in cancer. Heliyon, 6(9):e05000, September 2020. URL: http://dx.doi.org/10.1016/j.heliyon.2020.e05000, doi:10.1016/j.heliyon.2020.e05000. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.heliyon.2020.e05000)